Every day, we sift through the filings to spot where the real conviction lies β cutting through the noise to highlight the most meaningful insider moves.
π YPF $YPF β The Chairman, the CEO, as well as the VP of Upstream purchased $532,930 via Form 4.
A high-level insider cluster buy from the company's senior leadership team. When multiple top executives step in together, it often reflects a shared conviction.
π Absci $ABSI β Mary T. Szela purchased $148,866 via Form 4.
A small, but noteworthy insider purchase in the AI-driven drug discovery company.
Hereβs The Hot Corner, with data from July 6, 2026:
π Monte Rosa Therapeutics $GLUE β New Enterprise Associates 17 increased its stake from 4.90% to 7.90% via 13D.
The leading venture capital and healthcare investment firm significantly expanded its position, crossing the key 5% reporting threshold as the biotech stock works to complete a deep multi-year base.
π Quantinuum $QNT β Capital World Investors increased its stake from 10.40% to 13.90% via 13G.
The long-term institutional investor continued building an already sizable position in the recently public quantum computing company. Increasing ownership beyond 10% reflects a meaningful level of conviction in the company's long-term potential.
